Ligo Biosciences
Enzyme design models.
San Francisco, United States · Founded 2024
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2024
- Website
- ligo.bio
- Last Round
- SeedJan 2024
- Rounds
- 1
About
We are building the next generation of deep-learning models for enzyme design to slash the cost of chemical manufacturing. The $6 trillion chemical industry is flawed: It produces 20% of industrial greenhouse gases, and is responsible for 15% of global energy usage. Enzymes offer a far more sustainable alternative to chemical synthesis and have already revolutionised how a select few chemicals are produced. The problem is each enzyme takes years of trial and error to develop. Our enzyme models learn the principles of catalysis, allowing us to design enzymes for each reaction, in days not years.
Summary
Ligo Biosciences is an Artificial Intelligence company based in San Francisco, United States, founded in 2024. Its most recent funding was a Seed round in Jan 2024. Investors include Y Combinator Continuity Fund, 468 Capital and A.Capital Ventures.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Investors
Similar Companies
Self-driving cars.
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company

